Although I believe nicosan will be a great revenue earner, positive action on the FDA trials of HMF-5 (if started by mid 2007?) means this pps could well be a serious contender for percentage gainer of the year (2007)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.